Rocket Pharmaceuticals RCKT Q4 2024 Annual earnings
Reported February 27, 2025 · Before market open
EPS-$0.62Beat by $0.06
Revenue estimate$28.5K
EPS estimate-$0.68
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$222.2K
EPS estimate$1.04
Versus estimates
Diluted EPS
Ask the moment Rocket Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Rocket Pharmaceuticals report Q4 2024 earnings?
- Rocket Pharmaceuticals (RCKT) reported Q4 2024 earnings on February 27, 2025 before market open.
- What were Rocket Pharmaceuticals's Q4 2024 revenue and EPS?
- Rocket Pharmaceuticals reported eps of $-0.62 for Q4 2024.
- Did Rocket Pharmaceuticals beat estimates in Q4 2024?
- EPS beat the consensus estimate of $-0.68 by $0.06.
- Where can I find Rocket Pharmaceuticals's Q4 2024 SEC filings?
- You can read the 10-K periodic report (0000950170-25-029002) directly on SEC EDGAR. The filing index links above go to sec.gov.